Publicaciones en colaboración con investigadores/as de Paris Descartes University (45)

2019

  1. Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study

    Annals of Oncology, Vol. 30, Núm. 1, pp. 124-131

  2. ESC working group on cellular biology of the heart: Position paper for Cardiovascular Research: Tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure

    Cardiovascular Research, Vol. 115, Núm. 3, pp. 488-500

  3. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways

    Nature Communications, Vol. 10, Núm. 1

  4. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

    Nature Communications, Vol. 10, Núm. 1

  5. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification

    Human Mutation, Vol. 40, Núm. 9, pp. 1557-1578

  6. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study

    The Lancet Diabetes and Endocrinology, Vol. 7, Núm. 12, pp. 899-911

  7. Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: A prospective cohort study

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 7, pp. 979-987

  8. The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer

    npj Breast Cancer, Vol. 5, Núm. 1

2018

  1. Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: A Meta-analysis

    Journal of the National Cancer Institute, Vol. 110, Núm. 6, pp. 560-567

  2. Global overview of the transnational alliance for regenerative therapies in cardiovascular syndromes (TACTICS) Recommendations: A comprehensive series of challenges and priorities of cardiovascular regenerative medicine

    Circulation Research, Vol. 122, Núm. 2, pp. 199-201

  3. Multinational case-control study of risk factors for the development of late invasive pulmonary aspergillosis following kidney transplantation

    Clinical Microbiology and Infection, Vol. 24, Núm. 2, pp. 192-198

  4. Prosthetic Valve Candida spp. Endocarditis: New Insights into Long-term Prognosis-The ESCAPE Study

    Clinical Infectious Diseases, Vol. 66, Núm. 6, pp. 825-832

  5. Transplant results in adults with Fanconi anaemia

    British Journal of Haematology, Vol. 180, Núm. 1, pp. 100-109

2017

  1. Global position paper on cardiovascular regenerative medicine

    European Heart Journal

  2. Haploidentical transplant in patients with myelodysplastic syndrome

    Blood Advances, Vol. 1, Núm. 22, pp. 1876-1883

  3. Phase II randomized study of PM01183 versus topotecan in patients with platinum-resistant/refractory advanced ovarian cancer

    Annals of Oncology, Vol. 28, Núm. 6, pp. 1280-1287

  4. The consensus of the Task Force of the European Society of Cardiology concerning the clinical investigation of the use of autologous adult stem cells for the treatment of acute myocardial infarction and heart failure: Update 2016

    European Heart Journal, Vol. 38, Núm. 39, pp. 2930-2935

  5. The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: rationale and design of the BAMI trial

    European Journal of Heart Failure, Vol. 19, Núm. 11, pp. 1545-1550

2016

  1. Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future

    International Journal of Gynecological Cancer

  2. Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study

    American Journal of Transplantation, Vol. 16, Núm. 11, pp. 3220-3234